Officials at AstraZeneca report that their new medication, elecoglipron, helped people with type 2 diabetes reduce blood glucose levels and lose 10.5% of their body weight at 26 weeks
This balance underscores why multiple trial arms were necessary: without testing a range of dosages, investigators would not have uncovered these differences in outcome patterns
T.ChuC.JohnstonG
Claims Drawing Regulatory Attention FDA has indicated that compounded products generally should not be promoted using claims that: Suggest FDA approval Imply therapeutic equivalence Claim generic status without approval Guarantee clinical outcomes Misrepresent safety profiles Compare performance to approved products without evidence Marketing communications must be carefully reviewed to avoid misleading representations
Son also recommends products containing polydeoxyribonucleotide (PDRN), which are "barrier repairing and also contribute to cellular regeneration." In other words, they help repair the skin barrier while supporting new cell growth
In 2022, Congress gave Medicare the authority to negotiate drug prices directly with pharmaceutical companies for the first time, giving the program more sway to align its payments for prescription drugs with the actual value those drugs provide
